期刊文献+

血清胱抑素C与缺血性心衰患者及其近期预后关系的探讨 被引量:9

The investigation of relationship between serum cystatin C and the patients with ischemic heart failure and short term prognosis
下载PDF
导出
摘要 目的探讨血清胱抑素C(CysC)水平与缺血性心力衰竭(心衰)患者及近期预后的关系。方法收集并测定95例缺血性心衰患者及80例冠心病无心衰患者血清胱抑素、肌酐等指标,比较两组患者血清CysC水平;将心衰患者分为高CysC组及低CysC组,比较两组患者3个月心血管事件、病死率和再入院率情况差异;分析心衰组患者胱抑素与BNP、肌酐、C反应蛋白等的相关性。结果缺血性心衰患者较无心衰患者胱抑素C水平升高明显,差异具有统计学意义(P<0.05);高血清CysC组患者3个月心血管事件、病死率和再入院率明显增加,与低血清CysC组比较差异有统计学意义(P<0.05);相关分析显示血清CysC与肌酐、脑钠肽(BNP)呈显著正相关(P<0.05)。结论缺血性心衰患者血清CysC水平明显高于非心衰患者,血清CysC水平有可能成为诊断缺血性心衰的一标志物;CysC水平与缺血性心衰患者近期预后有密切的关系,血清CysC可能成为为缺血性心衰患者近期预后的预测因子。 Objective To investigate the relationship between Serum Cystatin C (CysC) and the patients with ischemic heart railure and short term prognosis. Methods The CysC and creatinine were collected and compared from the 95 patients with ischemic heart failure and 80 patients with non-ischemic heart failure; the patients with ischemic heart failure were devid ed into high CysC group and low CysC group, and the difference of cardiovascular events in three months, mortality and readmission rate of two groups were compared; the correlation of CysC, BNP, Creatinine and CRP were analysised in is chemic heart failure group. Results Compared with non-ischemic heart failure group, CysC of ischemic heart failure group was higher (P 〈 0.05); compared with low CysC group, the cardiovascular events in three month, mortality and readmission rate in high CysC group was higher (P 〈 0.05); the correlation analysis shows the CysC was significantly positive with BNP and creatinine (P 〈 0.05). Conclusion The CysC level of ischemic heart failure group was obviously higher than that of the non-is chemic heart failure group, and the CysC level may be one marker to diagnosis the ischemic hart failure; the CysC level was closely related with the prognosis of ischemic heart failure patients, and the CysC may be a predictor of the short term prognosis of ischemic heart failure patients.
出处 《中国现代医生》 2012年第23期128-129,共2页 China Modern Doctor
关键词 胱抑素C 缺血性心衰 脑钠肽 预后 Cystatin C Ischemic Heart Failure Brain Natriuretic Peptide Prognosis
  • 相关文献

参考文献8

  • 1万楠,王璐,罗军等.胱抑素C对急性蔻脉综合征患者的预后评估价值[J].国家检验医学杂志,2011,32(8):906-908.
  • 2Zahran A,Qureshi M,Shoker A.Comparison between creatinine and cystatin C-based GFR equations in renal transplantation [J]. Nephrol Dial Transplant, 2007,22 (9) : 2659-2668.
  • 3王超权,徐耕,程刚.血清胱抑素C水平对缺血性心力衰竭患者近期预后的影响[J].中国循环杂志,2009,24(1):28-31. 被引量:49
  • 4Ix JH,Shlipak MG,Chertow GM,et al. Association of Cystatin C With mort-ality, cardiovascular events, and incident heart failure among Per- sons with coro-nary heart disease:data from the Heart and Soul Study[J]. Circulation, 2007,115 (2) : 173-179.
  • 5徐敏,郑宏超,缪培智.血清高水平胱抑素C与心血管事件发生的关系探讨[J].现代中西医结合杂志,2011,20(10):1210-1210. 被引量:10
  • 6Sarnak MJ,Katz R,Stehman-Breen CO,et al. Cystatin C concentration as a risk factor for heart failure in older-adults [J]. Ann InternMed, 2005,142(7) :497-505.
  • 7Shlipak M G,Samak MG,Katz R,et al. Cystatin C and mortality in el- derly persons with heart failure[J]. JACC, 2005,45 (18):268-271.
  • 8周碧燕,吴署粤.胱抑素C与心血管疾病关系[J].内科,2011,6(5):480-482. 被引量:4

二级参考文献37

  • 1Filler G,Bokenkamp A,Hofmann W,et al.Cystatin C as a marker of GFR history,Indications and future research[J].Clin Biochem,2005,38(1):1-8.
  • 2Sarnak MJ,Katz R,Stehman-Breon CO,et al.Cystatin C concentration as a risk factor for heart failure in older adults.Ann Intern Med,2005,142(7):497-505.
  • 3陈灏珠译.心脏病学[M].第5版.北京:人民卫生出版社,2003.407-411.
  • 4Barka T,van der Noon H.Expression of the cysteine proteinase inhibitor Cystatin C gene in rat heart:use of digoxi-genin-labeled probes generated by polymerase chain reaction directly for in situ and northem blot hybridizations.J Histochem Cytochem,1993,41:1863-1867.
  • 5Bostom AG,Bausserman L,Jacques PF,et al.Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine.Arterioscler Thromb Vasc Biol,1999,19:2241-2244.
  • 6Sc hiffrin EL,Lipman ML,Mann JF.Chronic kidney disease:effects on the cardiovascular system.Circulation,2007,116:85-97.
  • 7Lassus J,Harjola VP,Sund R,et al.Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP.Eur Heart J,2007,28(15):1841-1847.
  • 8Ix JH,Shlipak MG,Chertow GM,et al.Association of cystatin C with mortality,cardiovascular events,and incident heart failure among persons with coronary heart disease:data from the Heart and Soul Study.Circulation,2007,115:173-179.
  • 9Dharnidharka VR, Kwon G,Stevens G. Serum cystatin C is superior to serum ereatinine as amarker of kidney function:a meta-analysis [ J ]. Am J Kidney Dis,2002,40:221 - 227.
  • 10McMahan CA,Gidding SS,McGill HC. Coronary heart disease risk factors and atherosclerosis in young people [ J ]. J Clin Lipidol, 2008,2(3) :118 - 126.

共引文献55

同被引文献68

引证文献9

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部